chinadaily.com.cn
|
english.gov.cn
Home
Policies
News
Specials
Topics
Regions
Home
>
Topics
>
Medical Products
>
News
China reports adverse reaction rate of 11.86 out of 100,000 COVID-19 vaccine doses
2021-05-31
Three-shot recombinant COVID-19 vaccines available in Beijing
2021-05-31
Efficacy of Sinopharm vaccines tops 70%, study finds
2021-05-31
Chinese inactivated vaccines effective against COVID-19 in phase-3 human trials: study
2021-05-28
2021 China-EU regulatory dialogue on pharmaceuticals held
2021-05-25
Inoculation of single-dose COVID-19 vaccine underway in Beijing
2021-05-21
Shanghai starts administering single-dose COVID-19 vaccine
2021-05-19
China approves one more inactivated COVID-19 vaccine for emergency use
2021-05-17
China's Sinopharm COVID-19 vaccine safe, efficacious: WHO official
2021-05-13
China to strengthen capabilities in drug administration
2021-05-11
Anti-cancer drugs more accessible for clinical use in China
2021-05-11
WHO approval of Sinopharm vaccine set to benefit world coronavirus fight
2021-05-10
WHO approves China's Sinopharm vaccine for emergency use
2021-05-08
Innovative super flu drug approved in China
2021-05-01
More anti-tumor drugs approved for use in China's hospital, with lower prices: health expert
2021-04-28
<
1
…
12
13
14
15
16
…
22
>
MOST POPULAR
1
China-Maldives free trade agreement to take effect
2
Longer public holidays prelude dynamic tourism in 2025
3
Visa-free policies brings more tourists to China
4
China to cut import tariffs on certain goods to expand domestic demand
5
Shanghai blazes path in growing debut economy
Editors' Picks
Video:
2024 year in review: China's exhibition highlights
Infographic:
Milestones in China's high-speed railway development
2025 Share your views on innovation and digitalization in China
Infographic:
China's NEV industry performance review
Infographic:
China's low-altitude economy: A transformative force
LEAVE YOUR MESSAGE
*Your E-mail Address
Copyright©2025 China Daily. All rights reserved.
京ICP备13028878号-6
京公网安备 11010502032503号